Who are Xylocaine and Dexamethasone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): lignocaine+dexamethasone.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/xylocaine-and-dexamethasone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Xylocaine and Dexamethasone — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Xylocaine and Dexamethasone (Xylocaine and Dexamethasone) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic + corticosteroid combination. Area: Pain management, Inflammation, Local anesthesia.

marketed Local anesthetic + corticosteroid combination Voltage-gated sodium channels (lidocaine); glucocorticoid receptor (dexamethasone) Pain management, Inflammation, Local anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Xylocaine and Dexamethasone (Xylocaine and Dexamethasone) — University of Jordan. Xylocaine (lidocaine) blocks nerve conduction by inhibiting sodium channels, while dexamethasone suppresses inflammatory and immune responses through glucocorticoid receptor activation.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Xylocaine and Dexamethasone TARGET	Xylocaine and Dexamethasone	University of Jordan	marketed	Local anesthetic + corticosteroid combination	Voltage-gated sodium channels (lidocaine); glucocorticoid receptor (dexamethasone)
lignocaine+dexamethasone	lignocaine+dexamethasone	Aligarh Muslim University	marketed	Local anesthetic + corticosteroid combination	Voltage-gated sodium channels (lignocaine); glucocorticoid receptor (dexamethasone)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic + corticosteroid combination class)

Aligarh Muslim University · 1 drug in this class
University of Jordan · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Xylocaine and Dexamethasone — Competitive Intelligence Brief. https://druglandscape.com/ci/xylocaine-and-dexamethasone. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab